Año 2022 / Volumen 114 / Número 5
Carta
MAFLD burden on the Spanish National Health System. A call to action

306-307

DOI: 10.17235/reed.2022.8606/2022

Daniel Riado Mínguez, María Luisa Gutiérrez García, Lorena Jara Fernández,

Resumen
We have read the editorial by Crespo et al on the metabolic associated liver disease (MAFLD) foreseeable burden on the Spanish National Health System over the next years. Between 0.35-0.4% of Spanish population has cirrhosis and more than one million people has significant fibrosis, assessed by ET ≥ 9 kPa. Compared with general population, patients with cirrhosis have more comorbidities and use healthcare resources more frequently. Recent data show a decrease of 24% in hospitalization due to cirrhosis during the period 2005-2014 in our country. These data predate the availability of direct antiviral agents against HCV. A 20% reduction of cirrhosis-related mortality during the period 2006-2018 was observed, as with other Southern European countries. This decline reflects a reduction of alcohol consumption in the last decades. More recently, 90% of patients with significant liver fibrosis were negative for HCV or HBV, did not consume harmful amounts of alcohol and showed components of metabolic syndrome thereby suggesting that MAFLD is the current leading cause of liver fibrosis in Spain. Some studies found that disadvantaged areas in the Community of Madrid had higher liver-related mortality, highlighting that lower income is another socioeconomic determinant of chronic liver disease.
Share Button
Nuevo comentario
Comentarios

09/05/2022 19:05:46
EJUQX


Bibliografía
1. Crespo J, Iruzubieta P, Lazarus JV. Can NAFLD overwhelm the Spanish healthcare system in the years to come? Rev Esp Enferm Dig. 2021 Dec 28;114:5-9. doi: 10.17235/reed.2021.8524/2021
2. Caballería L, Pera G, Arteaga I et al. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. Clin Gastroenterol Hepatol 2018;16:1138-1145. doi: 10.1016/j.cgh.2017.12.048
3. Fernandez Rodriguez CM, Fernández Pérez C, Bernal JL et al. RECALAD. Patient care at National Health System Digestive Care Units - A pilot study, 2015. Rev Esp Enferm Dig. 2018 Jan;110(1):44-50. doi: 10.17235/reed.2017.5316/2017
4. Blachier M, Leleu H, Peck-Radosavljevic M et al. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol 2013; 58: 593-608 doi: 10.1016/j.jhep.2012.12.005
5. Segura del Pozo J, Gandarillas A , Domínguez Berjón F et al. Chronic liver disease and cirrhosis mortality and social deprivation: a spatial analysis in small areas of Madrid region. Nutr Hosp. 2010;25:597-605
Artículos relacionados

Editorial

Tratamiento de la trombosis venosa portal en el paciente con cirrosis

DOI: 10.17235/reed.2023.9800/2023

Carta

Budd-Chiari syndrome in Behçet’s disease

DOI: 10.17235/reed.2022.9267/2022

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Carta

Hemoperitoneo por rotura de varices intraabdominales

DOI: 10.17235/reed.2022.8937/2022

Carta

Patrón cirrótico en la sarcoidosis hepática avanzada

DOI: 10.17235/reed.2021.8446/2021

Imagen en Patología Digestiva

Hepatocarcinoma quístico gigante en ausencia de cirrosis

DOI: 10.17235/reed.2021.8313/2021

Revisión

La fragilidad física en el contexto del trasplante hepático

DOI: 10.17235/reed.2020.7448/2020

Revisión

Pyroptosis in liver disease

DOI: 10.17235/reed.2020.7034/2020

Original

Colonic diverticulosis and the metabolic syndrome: an association?

DOI: 10.17235/reed.2017.5009/2017

Caso Clínico

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Instrucciones para citar
Riado Mínguez D, Gutiérrez García M, Jara Fernández L. MAFLD burden on the Spanish National Health System. A call to action. 8606/2022


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 694 veces.
Este artículo ha sido descargado 69 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 15/01/2022

Aceptado: 19/01/2022

Prepublicado: 21/01/2022

Publicado: 06/05/2022

Tiempo de prepublicación: 6 días

Tiempo de edición del artículo: 111 días


Compartir
Este artículo ha sido valorado por 1 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas